These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25421156)

  • 21. Cutting edge: the etiology of autoimmune thyroid diseases.
    Eschler DC; Hasham A; Tomer Y
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):190-7. PubMed ID: 21234711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology.
    Jacobson EM; Huber A; Tomer Y
    J Autoimmun; 2008; 30(1-2):58-62. PubMed ID: 18178059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves' animal models of Graves' hyperthyroidism.
    Nagayama Y
    Thyroid; 2007 Oct; 17(10):981-8. PubMed ID: 17822377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
    Hoang TD; Mai VQ; Clyde PW; Shakir MK
    Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmunity in thyroid disease.
    Collins J; Gough S
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S417-24. PubMed ID: 12192541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid autoimmunity.
    Wiersinga WM
    Endocr Dev; 2014; 26():139-57. PubMed ID: 25231450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility genes in thyroid autoimmunity.
    Ban Y; Tomer Y
    Clin Dev Immunol; 2005 Mar; 12(1):47-58. PubMed ID: 15712599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between a C/T polymorphism in exon 33 of the thyroglobulin gene is associated with relapse of Graves' hyperthyroidism after antithyroid withdrawal in Taiwanese.
    Hsiao JY; Hsieh MC; Tien KJ; Hsu SC; Shin SJ; Lin SR
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3197-201. PubMed ID: 17550957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic susceptibility to Graves' disease.
    Tomer Y; Davies TF
    Baillieres Clin Endocrinol Metab; 1997 Oct; 11(3):431-50. PubMed ID: 9532333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic and environmental factors in Graves disease. A review].
    Brix TH; Kyvik KO; Hegedüs L
    Ugeskr Laeger; 1998 Jan; 160(5):616-21. PubMed ID: 9470466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review.
    Brix TH; Kyvik KO; Hegedüs L
    Thyroid; 1998 Jul; 8(7):627-34. PubMed ID: 9709918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review.
    Brix TH; Kyvik KO; Hegedüs L
    Thyroid; 1998 Aug; 8(8):727-34. PubMed ID: 9737369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graves' disease: Epidemiology, genetic and environmental risk factors and viruses.
    Antonelli A; Ferrari SM; Ragusa F; Elia G; Paparo SR; Ruffilli I; Patrizio A; Giusti C; Gonnella D; Cristaudo A; Foddis R; Shoenfeld Y; Fallahi P
    Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101387. PubMed ID: 32107168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity.
    Dittmar M; Kahaly GJ
    Thyroid; 2005 Mar; 15(3):239-50. PubMed ID: 15785243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
    Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
    Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31.
    Tomer Y; Barbesino G; Keddache M; Greenberg DA; Davies TF
    J Clin Endocrinol Metab; 1997 May; 82(5):1645-8. PubMed ID: 9141566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a transgenic animal model of hyperthyroid Graves' disease.
    Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K
    Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic determinants of Graves disease.
    Chistyakov DA; Savost'anov KV; Turakulov RI; Nosikov VV
    Mol Genet Metab; 2000; 71(1-2):66-9. PubMed ID: 11001797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.